Actively Recruiting
Comparing Daily Tadalafil Alone Versus Combined With On-Demand PDE5 Inhibitors for Men With Resistant Erectile Dysfunction
Led by Al-Azhar University · Updated on 2026-09-01
260
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating daily tadalafil 5 mg as an additional therapy compared to daily tadalafil alone in men who have erectile dysfunction that does not improve with on-demand PDE5 inhibitors. This study aims to find out if combining therapies improves erectile function, treatment satisfaction, and partner satisfaction over 12 weeks. The trial is a randomized, parallel-group design focused on men aged 21 to 70 years with persistent erectile dysfunction despite prior PDE5 inhibitor use. Participants will be randomly assigned to one of two groups for 12 weeks. One group will take tadalafil 5 mg once daily plus their usual on-demand PDE5 inhibitor before sexual activity, while the other group will take tadalafil 5 mg once daily only. The on-demand PDE5 inhibitor will be taken 1 to 2 hours before sex, with a maximum of once daily. The study will monitor changes in erectile function and other measures during this treatment period. Participants will be assessed at the start and at weeks 4, 8, and 12. They will complete questionnaires about erectile function, treatment satisfaction, psychological well-being, and sexual performance during the study. Safety will be carefully monitored through vital signs, laboratory tests, and adverse event reporting. The main outcome is the change in erectile function score after 12 weeks of treatment. Partner satisfaction and treatment adherence will also be evaluated during the study.
CONDITIONS
Brief Title
Daily Tadalafil as Adjunctive Therapy Versus Monotherapy for PDE5 Inhibitor-Resistant Erectile Dysfunction
Research Team
A
Abul-fotouh Ahmed, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here